Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is not listed as a cause of heavy periods in its clinical trial data or prescribing information, but changes to your menstrual cycle (including heavier or more irregular bleeding) are something many women on tirzepatide notice and report. Here is what the clinical evidence actually shows, what may be driving those changes, and when it is worth speaking to someone. As a prescription-only medicine, Mounjaro requires a clinical assessment before it is prescribed; your prescriber is the right person to raise any new symptoms with.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is genuinely unsettling to notice a change in your cycle after starting a new medicine, especially when that medicine gets so much attention and the online forums are full of contradictory accounts. The short answer is that heavy periods are not a documented side effect in Mounjaro's UK prescribing information or the NHS tirzepatide medicine guide, tirzepatide acts on GIP and GLP-1 receptors involved in appetite and blood-sugar regulation, not directly on the hormones that govern your cycle. But that does not mean what you are experiencing is imaginary or unrelated to treatment.
Women in the SURMOUNT clinical programme who lost significant body weight reported menstrual changes, and reproductive endocrinologists have noted for years that rapid weight change (in either direction) can disrupt cycle regularity and flow. Fat tissue stores and converts oestrogen; as that tissue reduces, oestrogen levels can shift, affecting the feedback loop that governs ovulation, the thickness of the uterine lining and, consequently, how much you bleed. If you want a closer look at why your period may be heavier on Mounjaro and what to do about it, our dedicated page goes into the detail. That distinction matters practically: if the cause is weight-related hormonal change, the pattern often settles as your body finds a new equilibrium. If it does not, or if it worsens, that is a signal to investigate further. You can read more about how Mounjaro interacts with the menstrual cycle more broadly on our dedicated page.
Mounjaro does cause gastrointestinal side effects (nausea, changes in appetite, altered digestion) and those are well-documented. Gynaecological changes are not in that list. So before attributing heavier periods to tirzepatide, it is worth considering a few other possibilities that run alongside starting treatment.
First, timing. Many women begin Mounjaro at a point in their lives when hormonal shifts are already in flux, perimenopause, postpartum recovery, a change in contraception. A heavier period that coincides with starting Mounjaro may have a different cause entirely. Second, there is the contraception angle. The NHS England guidance on weight-management injections advises that oral contraceptives may be less reliably absorbed during the first four weeks of Mounjaro treatment and for four weeks after each dose increase, because tirzepatide slows gastric emptying. If the pill's hormones are absorbed less consistently, breakthrough bleeding or a heavier-than-usual period can follow. Adding a non-oral backup method during those windows is the standard recommendation.
Third, some conditions that cause heavy periods (fibroids, endometriosis, thyroid dysfunction) are more common in people with obesity and may become more noticeable as other symptoms change. Starting any new medicine is a useful prompt to check things you might have been putting off. Some women also wonder whether Mounjaro can stop periods altogether, a question our dedicated page addresses alongside the evidence on cycle suppression. You might also find our page on whether Mounjaro can trigger a period useful if your cycle has become unpredictable rather than simply heavier.
Most menstrual changes that emerge in the first few months on tirzepatide are not medically urgent, but there are circumstances where you should not wait for your next routine appointment. Contact your GP (or call 111 if your surgery is closed) if you are soaking through a pad or tampon every hour for two or more hours, passing clots larger than a 50p coin, feeling faint or dizzy, or if the heavier bleeding has continued for more than a week with no sign of settling.
Those symptoms can indicate anaemia or an underlying gynaecological condition that needs investigation regardless of what medicine you are taking. Your Mounjaro prescriber should also know: any significant new symptom after starting treatment is relevant to your ongoing clinical review. If you are considering starting Mounjaro and have an existing heavy-period condition, that is exactly the kind of detail a prescriber needs to know at assessment, it will not automatically rule you out, but it changes the picture. Our page on how Mounjaro affects periods covers the wider range of cycle changes that have been reported.
It is also worth knowing that Mounjaro is a prescription-only medicine under ongoing MHRA monitoring (it carries the Black Triangle ▼ status). If you experience a side effect you think may be linked to treatment, you can report it directly at the MHRA's Yellow Card scheme, patient reports genuinely shape how the evidence base develops.
A question our prescribers hear regularly is whether to stop Mounjaro if periods get heavier. The answer is almost never an immediate yes, but it is always worth raising. A clinician will want to know when the change started, how significant it is, what your cycle was like before, and whether you have any other symptoms. That context shapes whether the next step is watchful waiting, a gynaecology referral, a contraception review or something else.
At our pharmacy, every repeat prescription involves a clinical review by a GPhC-registered prescriber, a real clinician reads your check-in, not automated software. If a cycle change comes up in that review, it goes into the picture. If you are on Mounjaro through another provider and do not have access to that kind of ongoing clinical support, a conversation with your GP is the practical alternative. For those still weighing up whether tirzepatide is the right fit, exploring the full range of treatment options is a sensible starting point before committing. And if you have general questions about what life on tirzepatide involves, our tirzepatide overview covers the detail.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.